RxDoctor Payments Data

Deepak Sharma

Physician Assistant · Scottsdale, AZNPI 1730736182

Payments from drug & device makers

$2,269in general payments, 2019–2025

Across 22 payments — averaging $103.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Actelion Pharmaceuticals US, Inc.$279
  • Bayer$200
  • Kestra Medical Technology Services, Inc.$194
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$126
  • Alnylam Pharmaceuticals Inc.$120

What the payments were for

  • Consulting fees$2009%
  • Travel & lodging$97343%
  • Food & beverage$1,09648%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,269 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$99,265
Medicare patients
405
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan269$332,947
VyndamaxTafamidis15$328,421
UptraviSelexipag11$202,681
EliquisApixaban159$186,986
JardianceEmpagliflozin178$170,129
FarxigaDapagliflozin Propanediol93$115,223
XareltoRivaroxaban17$28,231
Repatha SureclickEvolocumab11$8,285
Torsemide202$4,742
Eplerenone45$3,886
Metoprolol Succinate194$2,729
Potassium Chloride114$1,934
Spironolactone165$1,239
Amiodarone Hcl71$1,176
Carvedilol132$1,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Uptravi$279$202,68111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →